Pharmacovigilance assessment of the association between Fournier's gangrene and other severe genital adverse events with SGLT-2 inhibitors.
Fadini GP, Sarangdhar M, De Ponti F, Avogaro A, Raschi E.
BMJ Open Diabetes Res Care. 2019 Oct 4;7(1):e000725. doi: 10.1136/bmjdrc-2019-000725. eCollection 2019.
PMID:31641524
Fatal Fournier's gangrene caused by Clostridium ramosum in a patient with central diabetes insipidus and insulin-dependent diabetes mellitus: a case report.
Takano N, Yatabe MS, Yatabe J, Kato M, Sueoka D, Iguchi S, Yoshida A, Uzawa Y, Kikuchi K, Tani K, Ogawa S, Itabashi M, Yamamoto M, Watanabe D, Ando T, Morimoto S, Ichihara A.
BMC Infect Dis. 2018 Aug 2;18(1):363. doi: 10.1186/s12879-018-3280-9.
PMID:30071825
Factors Affecting Mortality in Fournier Gangrene: A Single Center Experience.